ASTX660 Uses, Dosage, Side Effects and more

ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).

Trade Name ASTX660
Generic ASTX660
Type
Formula C30H42FN5O3
Weight Average: 539.696
Monoisotopic: 539.327168395
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share